Karyopharm Therapeutics
KPTI
KPTI
85 hedge funds and large institutions have $285M invested in Karyopharm Therapeutics in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
85
Holders Change
-4
Holders Change %
-4.49%
% of All Funds
2.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
37
Reduced
22
Closed
14
Calls
$2.38M
Puts
$1.91M
Net Calls
+$474K
Net Calls Change
-$7.02M
Top Buyers
| 1 |
Millennium Management
New York
|
+$3.56M |
| 2 |
JPMorgan Chase & Co
New York
|
+$1.81M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$1.64M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$630K |
| 5 |
OPPM
Opus Point Partners Management
New York
|
+$600K |
